 |
Neural Probes |
|
| |
Overview |
In even
its simplest conceptualization, the human brain is the
most complicated mechanism on the planet. Humans have
yet to uncover most of its mysteries despite decades of
intense study. Like most machines, errors can occur within
the brain for various reasons and often result in demonstrable
functional deficits or excesses. These deficits and excesses
often inhibit a patient’s ability to function in
the everyday world, and depending upon the disease, even
tasks such as brushing one’s teeth or tying one’s
shoes can become a challenge.
In hospitals across the country, research
is being conducted to better understand the mechanisms
of diseases such as epilepsy, Parkinson’s, and
depression through the systematic study of brain chemistry.
NanoTechLabs, in conjunction with several commercial
research partners, is developing miniaturized neural
probes to monitor changes in levels of neurotransmitters
or low molecular weight (< 5000 Da) chemicals in
the brain. The nanomaterials composing NanoTechLabs’
sensors cause less scar tissue and stimulate neurons
to grow 60 percent more fingerlike extensions (these
extensions are needed to regenerate brain activity in
damaged regions).
A variety of treatments has developed
from the growing volume of research and can alleviate
disease symptoms to varying degrees. Deep brain stimulation
(DBS) is a technique much like a heart pacemaker that
uses periodic electrical impulses to stimulate tissue.
It has shown promise in recent clinical trials minimizing
Parkinsonian symptoms, depression, and epileptic seizures
in over half of the patients.
NanoTechLabs’ sensors
are currently being developed as functional platforms
for this treatment. Within a decade, one can imagine
a world where patients suffering from localized neurological
diseases are no longer removed to a world of deficit
or excess, but through deep brain stimulation become
empowered to live a normal life. |
| |
| |
Applications |
NanoTechLabs’
neural probes have several clinical applications including:
- Neurotransmitter sensing
- Deep brain stimulation platforms
|
| |
| |
Research Status |
| NanoTechLabs’
neural probes will be seeking FDA approval in three years. |
| |
| |
| |
|